← Leaderboards
Scott M. Freeman
Savant Hwp, Inc.
$6,796,064
Attributed
$6,796,064
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2012–14$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
Funding mix
By agency
NIH$6,796,064 · 1
By mechanism
U01$6,796,064 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAlcoholsAmygdaloid StructureAnimal ModelAnimalsApplications GrantsAttenuatedBaseBehaviorBone MarrowCanis FamiliarisCannabisCardiacCardiovascular SystemCholinergic ReceptorsChromosome AbnormalityClinicClinical ResearchCocaineCocaine AbuseCocaine UseContractsCoronardineAction Potentials
Grant awards (3)
IND-enabling Studies and GMP Scale-up of 18-Methoxycoronaridine hydrochloride(18-$620,161
U01 · FY2014 · DA · contact PI
IND-enabling Studies and GMP Scale-up of 18-Methoxycoronaridine hydrochloride(18-$2,507,295
U01 · FY2013 · DA · contact PI
IND-enabling Studies and GMP Scale-up of 18-Methoxycoronaridine hydrochloride(18-$3,668,608
U01 · FY2012 · DA · contact PI